<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04746196</url>
  </required_header>
  <id_info>
    <org_study_id>2016/85</org_study_id>
    <nct_id>NCT04746196</nct_id>
  </id_info>
  <brief_title>Galectin-3 Level in Ankylosing Spondylitis Patients</brief_title>
  <official_title>Relationship Between Galectin-3 Level and Disease Activity in Ankylosing Spondylitis Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Recep Tayyip Erdogan University Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Recep Tayyip Erdogan University Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Forty-five AS patients and 35 healthy controls were enrolled in this study. Patients&#xD;
      diagnosed with AS according to Modified New York criteria were included in the study.&#xD;
      Clinical and laboratory measurements, duration of symptoms, age and body mass index (BMI) of&#xD;
      AS patients were performed and compared with age and BMI matched control group.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Detailed histories of all participants were obtained, and systemic and rheumatologic&#xD;
      examinations were performed. We excluded all participants who had a history of&#xD;
      hyperlipidemia, liver, renal, hematological, familial thyroid, neoplastic, autoimmune&#xD;
      infectious diseases and receiving anti-inflammatory drugs.&#xD;
&#xD;
      We measured serum galectin-3 levels using a commercial chemiluminescent microparticle&#xD;
      immunoassay. The Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) was used to&#xD;
      assess disease activity in AS patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Actual">August 30, 2017</completion_date>
  <primary_completion_date type="Actual">June 30, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Relationship Between Galectin-3 Level and Disease Activity in Ankylosing Spondylitis Patients</measure>
    <time_frame>5 months</time_frame>
    <description>Correlation</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">80</enrollment>
  <condition>Ankylosing Spondylitis</condition>
  <arm_group>
    <arm_group_label>45 ankylosing spondylitis patients.</arm_group_label>
    <description>Patients diagnosed with ankylosing spondylitis according to Modified New York criteria were included in the study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>35 controls</arm_group_label>
    <description>Healthy controls</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Serum galectin-3 concentration was measured.</intervention_name>
    <description>Serum galectin-3 concentration was measured using a commercial chemiluminescent microparticle immunoassay.</description>
    <arm_group_label>35 controls</arm_group_label>
    <arm_group_label>45 ankylosing spondylitis patients.</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Ankylosing spondylitis patients and healthy controls&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Ankylosing spondylitis patients&#xD;
&#xD;
          -  Healthy controls&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Hyperlipidemia&#xD;
&#xD;
          -  Liver diseases&#xD;
&#xD;
          -  Renal diseases&#xD;
&#xD;
          -  Hematological diseases&#xD;
&#xD;
          -  Familial thyroid diseases&#xD;
&#xD;
          -  Neoplastic diseases&#xD;
&#xD;
          -  Autoimmune infectious diseases&#xD;
&#xD;
          -  Receiving anti-inflammatory drugs.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>February 4, 2021</study_first_submitted>
  <study_first_submitted_qc>February 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 9, 2021</study_first_posted>
  <last_update_submitted>April 17, 2021</last_update_submitted>
  <last_update_submitted_qc>April 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Recep Tayyip Erdogan University Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Gul Devrimsel</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spondylitis</mesh_term>
    <mesh_term>Spondylitis, Ankylosing</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

